Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study

CSF biomarkers, including total-tau, neurofilament light chain (NfL) and amyloid-β, are increasingly being used to define and stage Alzheimer's disease. These biomarkers can be measured more quickly and less invasively in plasma and may provide important information for early diagnosis of Alzhe...

Full description

Bibliographic Details

Published in:	Brain (London, England : 1878) Vol. 143; no. 4; p. 1220
Main Authors:	de Wolf, Frank, Ghanbari, Mohsen, Licher, Silvan, McRae-McKee, Kevin, Gras, Luuk, Weverling, Gerrit Jan, Wermeling, Paulien, Sedaghat, Sanaz, Ikram, M Kamran, Waziry, Reem, Koudstaal, Wouter, Klap, Jaco, Kostense, Stefan, Hofman, Albert, Anderson, Roy, Goudsmit, Jaap, Ikram, M Arfan
Format:	Journal Article
Language:	English
Published:	England 01.04.2020
Subjects:	dementia plasma biomarkers Alzheimer’s disease Aβ42 NfL
ISSN:	1460-2156, 1460-2156
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!